Newsfeeds - Spark Newswire

5 minute read

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

September 2, 8:19 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

5 minute read

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

By Shanthi Rexaline

August 31, 8:05 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)

ABSI

3 minute read

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

By Shanthi Rexaline

August 19, 7:37 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18)

ABBV

8 minute read

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

By Shanthi Rexaline

August 17, 8:28 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16)

ABSI

6 minute read

78 Biggest Movers From Friday

By Lisa Levin

August 16, 5:12 AM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.

ABCL

6 minute read

66 Biggest Movers From Yesterday

By Lisa Levin

August 12, 5:27 AM

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share.

ABST

4 minute read

48 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

August 11, 12:03 PM

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) gained 82% to $25.19. The company, last month, priced its IPO at $11 per share.

ABST

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

August 11, 8:14 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

1 minute read

Crinetics’ Single Ascending Dose Data Shows Proof Of ACTH Antagonism In Healthy Volunteers

By Vandana Singh

August 11, 7:19 AM

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) announced preliminary findings from the single ascending dose (SAD) portion of Phase 1 study evaluating CRN04894 for…

CRNX

1 minute read

Crinetics Pharmaceuticals Q2 EPS $(0.70) Down From $(0.53) YoY

By Benzinga Newsdesk

August 10, 4:24 PM

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.70) per share. This is a 32.08 percent decrease over losses of $(0.53) per share from the same period last year.

CRNX